Hormonal and Immunologic Methods in the Diagnosis and Treatment of Patients with Benign Ovarian Tumors and Endometriotic Cysts
Overview
Reproductive Medicine
Affiliations
Objective: To compare efficacy of various methods for characterizing endometriosis and benign ovarian tumors.
Design: Two parallel groups of patients, 54 with endometriotic ovarian cysts and 48 with benign tumors.
Setting: Central clinic.
Patients: Patients referred from all regions over a 5-year period.
Outcome Measures: Estrogen Estrogen and progesterone receptor levels of endometrium and endometriotic foci, CA-125 concentration, and estradiol, progesterone, LH, and testosterone blood levels.
Results: LH levels elevated during follicular phase in patients; estradiol levels reduced; receptor levels abnormal in endometriosis, but not in benign ovarian cysts.
Conclusions: Hormone therapy is adequate treatment for endometriotic cysts. CA-125 is not a reliable indicator for differential diagnosis.
Combination of the non-invasive tests for the diagnosis of endometriosis.
Nisenblat V, Prentice L, Bossuyt P, Farquhar C, Hull M, Johnson N Cochrane Database Syst Rev. 2016; 7:CD012281.
PMID: 27405583 PMC: 6953325. DOI: 10.1002/14651858.CD012281.
Blood biomarkers for the non-invasive diagnosis of endometriosis.
Nisenblat V, Bossuyt P, Shaikh R, Farquhar C, Jordan V, Scheffers C Cochrane Database Syst Rev. 2016; (5):CD012179.
PMID: 27132058 PMC: 7076288. DOI: 10.1002/14651858.CD012179.
Endometrial biomarkers for the non-invasive diagnosis of endometriosis.
Gupta D, Hull M, Fraser I, Miller L, Bossuyt P, Johnson N Cochrane Database Syst Rev. 2016; 4:CD012165.
PMID: 27094925 PMC: 6953323. DOI: 10.1002/14651858.CD012165.
Peripheral biomarkers of endometriosis: a systematic review.
May K, Conduit-Hulbert S, Villar J, Kirtley S, Kennedy S, Becker C Hum Reprod Update. 2010; 16(6):651-74.
PMID: 20462942 PMC: 2953938. DOI: 10.1093/humupd/dmq009.